The North America Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market is experiencing robust growth, driven by the increasing prevalence of advanced prostate cancer, rising adoption of targeted therapies, and continuous advancements in oncology treatment. The region benefits from a well-established healthcare infrastructure, strong investment in cancer research, and...
